QDRO Acquisition
QADRW · NASDAQ
QADRW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 20
- Volume
- 2.50K
- Open price
- $0.1901
- High today
- $0.1901
- Low today
- $0.19
- 52 Week high
- $0.40
- 52 Week low
- $0.18
QDRO Acquisition (QADRW) at a glance
QDRO Acquisition (QADRW) last traded at $0.1901, with a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.19 and $0.1901. The current price is 0.1% above the day's low and 0.0% below its high.
Volume so far is 2.50K shares, above the average of 20 shares a day.
Over the past year QDRO Acquisition has ranged from $0.18 to $0.40, and now sits 5% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- CYABCyabra$0.1368+53.71%
- NVDANVIDIA$156.14−4.12%
- RWAXTAP Real Estate Technologies$0.0001−50.00%
- DVLTDatavault AI$0.028−53.33%
- IFXYInfrax Systems$0.0005−16.67%
- SHFSSHF Holdings$0.023−24.09%
- TIPSTianrong Internet Products & Services$0.0007+16.67%
- SOXLDirexion Shares ETF Trust$48.76−16.39%
- AXXAExxe Group$0.0004−12.50%
- EARIEntertainment Arts Research$0.0002+0.00%
- GDHGGolden Heaven Group Holdings$1.58+91.45%
Newly listed
Companies that went public in the past six weeks
- NARANarragansett Bancorp$10.48−1.13%
- ASPEAspen Neuroscience$12.23−2.86%
- BBTXBambusa Therapeutics$15.98−0.68%
- GBCGEORGIA BANKING$34.48+1.08%
- BHAIUBHAV Acquisition Corp II$10.02+0.10%
- SCQCUSPACCircle Acquisition$10.01−0.10%
- LYCALycia Therapeutics$28.61−8.30%
- DAVIDAVION HEALTHCARE$1.02+2.00%
- TCXBTCGX Acquisition Corp. II$10.25+0.89%
- CTYCITY THERAPEUTICS$16.98−6.19%
- IAMIambic Therapeutics$11.85−9.54%
- AMROAmaero$5.63+2.36%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.